Tomorrow marks the start of #ASCO25. We're excited to present 23 abstracts and explore new data from the global #oncology community.
Visit us at Booth 30071 and check out our online hub for more information: https://t.co/lZckNOehFm
#BeOneAtASCO
May is Mental Health Awareness Month – let's #TalkAboutIt.
We believe mental health support can improve quality of life and health outcomes for people impacted by cancer. Our Talk About It: Cancer and Mental Health program provides innovative support strategies and elevates mental health conversations to support people throughout their entire cancer journey.
The first step? Talking about it. Learn more & find resources here: https://t.co/Z8DO5Bel2E
#MentalHealth #CancerHasNoBorders
The @US_FDA has approved new dosing options for our PD-1 inhibitor in both first- and second-line esophageal squamous cell carcinoma (#ESCC) and first-line gastric cancer, providing more flexibility for pairing our immunotherapy with the most common chemotherapy regimens.
This approval reinforces our dedication to patients in the U.S. living with upper GI cancers—helping to expand access to personalized treatment approaches and supporting providers in delivering care that fits the unique needs of each patient.
I was honored to receive a @MaxwellFootball Mini-Maxwell Award tonight along with many great athletes from PA, NJ and DE. It was a great way to end my high school football career. And I’m grateful to my teammates and coaches for the last 4 years together @camphillfb@Coach_JLynch@timbigelow
Antibody-drug conjugates (ADCs) hold promise as potential smart bomb therapies for cancers, but these complex molecules are challenging to manufacture. We’ve built in-house ADC manufacturing capabilities hand-in-hand with our technology innovations, which enables efficient discovery research testing of new molecule designs, as well as clinical and commercial scale production of pipeline candidates.
Read more about our enhanced ADCs here: https://t.co/f82wyj35R1
#ADC #Oncology #DrugDiscovery
ICYMI: We recently partnered with @CllSociety to advance #TestBeforeTreat, a campaign emphasizing the importance of biomarker testing for patients with #CLL and #SLL. Together, we aim to educate patients and healthcare providers on the role of biomarker testing in guiding personalized care and improving outcomes. Read more in this @FiercePharma article: https://t.co/l5opY5VbVm
At the most crucial time in Friday night’s District 3 Class 2A championship game, @camphillfb quarterback Drew Branstetter owned the moment and guided his Lions to their 11th district title in school history, 20-13 over @thsshamrocks.
https://t.co/55UfKzJPk8
Confidence, quick start power Camp Hill football to District 3 semifinal win over Annville-Cleona | Tap on the picture to learn more 🔽 https://t.co/giQtpOBpRY
The excitement is high at @camphillfb, as described here by Luke Becker, Drew Branstetter, Tommy Corbin and Kobe Moore.
The Lions returned to the District 3 2A playoffs last year, and have gold medals in mind this fall.
"Having the energy on the bench all the time really can change who a team is and what it really defines about a team.”
Local teams channeled their dugout energy through cheers, celebrations and conversations and used the chatter to fuel momentum.
https://t.co/FiCDAPjovV